The inhaled aerosol vaccine is far more effective at inducing protective immune responses than traditional injections, targeting the lungs and upper airways where viruses first enter the body and providing long-lasting protection against respiratory infections.
Seven McMaster-led research projects are receiving funding from the Clinical Trials Fund, designed to enhance Canada’s clinical trials ecosystem from discovery to implementation.
A team of researchers at McMaster University is working on an inhaled COVID-19 vaccine that offers better protection and is less costly to produce, store and ship.
McMaster logo
McMaster logo
